|
Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia |
I Care I Cure |
|
Pediatric Developmental Therapeutics Center of Excellence at UCSF |
University of California San Francisco |
I Care I Cure |
|
Development of a Childhood Leukemia Translational Research Program |
Dana-Farber Cancer Institute |
I Care I Cure |
|
Phase I and II Clinical Research Program Infrastructure Award - Brenda Weigel, MD/MSc (2011) |
University of Minnesota |
Northwestern Mutual Foundation |
|
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia |
Vanderbilt University Medical Center |
I Care I Cure |
|
Mechanisms of Oncogenic Transformation by TLX1/HOX11 |
University of Michigan |
I Care I Cure |
|
Targeted Polymeric Parthenolide Carriers to Treat Childhood AML |
University of Rochester |
I Care I Cure |
|
131 I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal |
University of California San Francisco |
I Care I Cure |
|
Discovery of Inhibitors of MLL Fusion Proteins as Targeted Therapies for Pediatric Acute Leukemia |
Nemours Center for Childhood Cancer Research |
I Care I Cure |
|
Immune Stimulatory Antigen Loaded Particles (ISAPS) for the Treatment of Solid Childhood Tumors
|
Children’s National Medical Center |
|
